Explore GE Healthcare's Q3 2025 financial performance with $5.143B in revenue but declining net income. Key insights on segment growth and debt management included.
Discover crucial insights from GE Healthcare Technologies Inc.'s 8-K filing on October 29, 2025, including stock info and corporate changes. Stay informed on your investments!
Explore GE HealthCare's Q2 2025 financial performance with solid revenue growth, net income rise, and restructuring costs. Key insights and future outlook included.
Explore GE Healthcare Technologies Inc.'s latest 8-K filing for critical updates on operations and financials as of July 30, 2025. Stay informed on stock impacts and corporate events.
Explore GE Healthcare Technologies Inc.'s 8-K filing, revealing essential financial data for May and July 2025. Stay informed on stock performance and company updates.
Explore GE Healthcare Technologies Inc.'s 8-K report detailing significant corporate events on June 9, 2025. Stay informed on regulatory compliance and market implications.
Explore GE Healthcare's essential 8-K report from June 3, 2025, detailing key company insights, stock info, and significant changes vital for stakeholders.
Explore GE Healthcare Technologies Inc.'s latest 8-K filing from May 28, 2025, detailing significant updates for investors and analysts. Stay informed about key financial events.
Explore GE HealthCare's Q1 2025 financial performance, highlighting revenue growth, net income rise, and ongoing legal risks. Should investors hold their positions?
Discover significant updates from GE Healthcare Technologies Inc. in their April 30, 2025, 8-K report. Key insights for investors and stakeholders on corporate changes and stock performance.
Discover vital updates from GE Healthcare Technologies Inc. in this 8-K report, covering significant corporate changes and insights for investors. Filed on March 27, 2025.
Explore GE HealthCare's robust financial performance, strategic acquisitions, and investment potential in this comprehensive 2024 report. Discover key metrics and insights.